Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine A DRAFT PACKAGE OF INTERVENTIONS.

Slides:



Advertisements
Similar presentations
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Advertisements

Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
Clinical Alliances and Partnerships Raul A. Romaguera, DMD, MPH Division of HIV/AIDS Prevention Centers for Disease Control and Prevention March 11, 2004.
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Prevention of Mother-to-Child Transmission of HIV in Ghana
Thailand’s HIV and AIDS STRATEGY
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Advancing the prevention and treatment of chronic illnesses UCLA Department of Family Medicine Psychoactive Drugs and HIV Steven Shoptaw, PhD UCLA Center.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Predictors of HIV Transmission Risk among Patients in Care: Results from the SPNS Prevention with Positives Initiative Stephen F. Morin, PhD Principal.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
“Writing our own narratives” The Global Advocacy Agenda for Young People Living with HIV.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
The National HIV and AIDS Strategy is the overarching framework for everyone at all levels to guide and drive the expanded response to HIV, AIDS and STI’s.
HIV and drug prevention in Estonia Harm reduction services
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
Treatment of drug addiction in prisons
1 Data Collection in MARA – Integration in national IHBSS Example: Philippines Gudrun Nadoll, HIV Specialist, UNICEF Philippines September 3, 2009, MARA.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
11 Programme Strategies for Postpartum Family Planning: A new resource for FP programmes Mary Lyn Gaffield, PhD November 2013 Scientist, Human Reproduction.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
One-size does not fit all: Importance of all- inclusive HIV prevention HIV-Prevention:update on global and Finnish HIV situation and new preventive technologies.
Scaling-up male circumcision programmes in the Eastern and Southern Africa region Country Update Meeting June 2010 Dr Sibongile Dludlu UNAIDS RST/ESA.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Epidemiological Impact and Cost Effectiveness of Harm Reduction Programmes in Russia Based on the results of the Global Fund Round 5 HIV Programme in Russia,
Resource Needs Model Rachel Sanders October 28 th, 2010.
HIV Services for Young People A Regional Perspective from the Caribbean Korey Chisholm UNAIDS Special Youth Fellow Guyana 2008.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
Global Monitoring & Evaluation of HIV Prevention Among Most-at-Risk Populations: Update on existing guidance Priscilla Akwara, PhD Senior Advisor, Statistics.
PLACE Method Priorities for Local AIDS Control Efforts 1 1 MEASURE Evaluation, A Manual for implementing the PLACE Method.
The Multi-Sectoral Provincial Strategic Plan for HIV & AIDS, STIs & TB of KwaZulu-Natal Presentation to PEPFAR all partners meeting Monday 28.
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
New Prevention Technologies Workshop Module 2: NPTs in context
Control of Sexually Transmitted Infections (STI) in Guyana: Plan to Integrate into Existing Programmes Scotland, S 1 ; Singh, S 1 ; Hernandez, R 2 ; Springer,
Implementing HIV/AIDS Standard Bidding Clauses Christopher R. Bennett Lead Transport Specialist, GTIDR.
High Coverage of Most-at-Risk Populations Reduces HIV Risk: Results from Central Asia Anna Deryabina, David S. Hausner, Bibigul Aubakirova, Yana Dobronravova,
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade.
#AIDS2016 HOW TO LAUNCH PROGRAMMES FOR PEOPLE WHO USE SUBSTANCES AND ARE AFFECTED BY HIV ACROSS MORE GENERALIZED HIV EPIDEMIC SETTINGS.
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Primary Investigator: Prof. P Reddy Project Director: Ms S James
Richard hayes London school of hygiene & Tropical Medicine
People who inject drugs
Edward Mbizo Sibanda, (MSc) Right to Care
Myanmar Last Update: November 2014.
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
Targets and Indicators Monitoring and Evaluation
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine A DRAFT PACKAGE OF INTERVENTIONS FOR ENSURING ACCESS TO HIV PREVENTION, TREATMENT, AND CARE FOR STIMULANT USERS

OVERVIEW OF DOCUMENT Introduction/rationale Background Intervention package for HIV prevention, treatment and care for people who use stimulant Target-setting process Annexes: Methodology for developing document Framework for setting indicators and targets

RIGHT OFF: Page 1: Stimulant users are a diverse group and importance of ensuring access to HIV prevention, treatment and care can be different across groups Type of stimulant used Route of administration Contexts of stimulant use Each of these factors introduce important and unique ways in which access is limited for stimulant users

CRITERIA APPLIED TO REVIEW OF INTERVENTIONS Must focus on HIV or AIDS Include an outcome evaluation Target stimulant users use within last 12 months crack/cocaine and or ATS as the primary drug in mixed samples: >50% report stimulant use, regardless of route of administration Report 1 or more HIV outcomes HIV-related sexual behaviours (# sex partners, condom use) HIV-related drug use behaviours (injection use, sex for drug) HIV biomarkers (VL, CD4, incidence or prevalence)

PACKAGE OF INTERVENTIONS 1.HIV testing and counselling 2.Antiretroviral therapy 3.Drug dependence treatment 4.Condom distribution programmes 5.Needle and syringe programmes for those who inject stimulants 6.Behavioural interventions aimed to reduce HIV transmission 7.Screening, prevention, and treatment of HCV, HBV, STIs, and TB 8.Targeted information, education, communication programmes 9.Voluntary medical male circumcision

NEXT STEPS Electronic consultation Revised draft of technical guidelines Circulate to advisors Review of feedback with integration of comments Preparation of document for distribution

PROJECT TIMELINE FebJanDecNovOctSept Conduct lit search Electronic consultation Integrate feedback Global Expert Meeting Compile & synthesize evidence and draft guide Integrate feedback Jan-endJuly Mar - Jun Nov-DecSep-Oct Document production & release Consensus, Guidance & approval Electronic consultation AIDS 2012 meeting Production and comments

Steve Shoptaw PhD COMMENTS/QUESTIONS